Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

Pigeon foot feathering reveals conserved limb identity networks.

Boer EF, Van Hollebeke HF, Park S, Infante CR, Menke DB, Shapiro MD.

Dev Biol. 2019 Jun 24. pii: S0012-1606(19)30274-X. doi: 10.1016/j.ydbio.2019.06.015. [Epub ahead of print]

2.

Future role of proprotein convertase subtilisin/kexin type 9 inhibitors in preventive cardiology.

Mahmood T, Shapiro MD.

Curr Opin Cardiol. 2019 Jun 24. doi: 10.1097/HCO.0000000000000657. [Epub ahead of print]

PMID:
31246589
3.

Translating AHA/ACC cholesterol guidelines into meaningful risk reduction.

Wójcik C, Shapiro MD.

J Fam Pract. 2019 May;68(4):206;210;212;214;217;221B.

PMID:
31226173
4.

Rapid experimental evolution of reproductive isolation from a single natural population.

Villa SM, Altuna JC, Ruff JS, Beach AB, Mulvey LI, Poole EJ, Campbell HE, Johnson KP, Shapiro MD, Bush SE, Clayton DH.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13440-13445. doi: 10.1073/pnas.1901247116. Epub 2019 Jun 10.

PMID:
31182608
5.

Aspirin for Primary Prevention of Cardiovascular Disease.

Kheiri B, Barbarawi M, Bachuwa G, Shapiro MD.

Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005846. doi: 10.1161/CIRCOUTCOMES.119.005846. Epub 2019 Jun 5. No abstract available.

PMID:
31163982
6.

The PCSK9 revolution: Current status, controversies, and future directions.

Warden BA, Fazio S, Shapiro MD.

Trends Cardiovasc Med. 2019 May 21. pii: S1050-1738(19)30072-6. doi: 10.1016/j.tcm.2019.05.007. [Epub ahead of print] Review.

7.

Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy.

Warden BA, Minnier J, Watts GF, Fazio S, Shapiro MD.

J Clin Lipidol. 2019 Apr 26. pii: S1933-2874(19)30084-4. doi: 10.1016/j.jacl.2019.04.008. [Epub ahead of print]

PMID:
31130489
8.

Host defense triggers rapid adaptive radiation in experimentally evolving parasites.

Bush SE, Villa SM, Altuna JC, Johnson KP, Shapiro MD, Clayton DH.

Evol Lett. 2019 Mar 5;3(2):120-128. doi: 10.1002/evl3.104. eCollection 2019 Apr.

9.

Interpreting the Findings From the Recent PCSK9 Monoclonal Antibody Cardiovascular Outcomes Trials.

Wong ND, Shapiro MD.

Front Cardiovasc Med. 2019 Mar 6;6:14. doi: 10.3389/fcvm.2019.00014. eCollection 2019. Review.

10.

A four-questions perspective on public information use in sticklebacks (Gasterosteidae).

Webster MM, Chouinard-Thuly L, Herczeg G, Kitano J, Riley R, Rogers S, Shapiro MD, Shikano T, Laland KN.

R Soc Open Sci. 2019 Feb 20;6(2):181735. doi: 10.1098/rsos.181735. eCollection 2019 Feb.

11.

Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab.

Shapiro MD, Minnier J, Tavori H, Kassahun H, Flower A, Somaratne R, Fazio S.

J Am Heart Assoc. 2019 Feb 19;8(4):e010932. doi: 10.1161/JAHA.118.010932.

12.

Brief Commentary: Marijuana and Cardiovascular Disease-What Should We Tell Patients?

Kaufman TM, Fazio S, Shapiro MD.

Ann Intern Med. 2019 Jan 8. doi: 10.7326/M18-3009. [Epub ahead of print] No abstract available.

PMID:
30615780
13.

Application of PCSK9 Inhibitors in Practice.

Kaufman TM, Warden BA, Minnier J, Miles JR, Duell PB, Purnell JQ, Wojcik C, Fazio S, Shapiro MD.

Circ Res. 2019 Jan 4;124(1):32-37. doi: 10.1161/CIRCRESAHA.118.314191.

PMID:
30605414
14.

The Intersection of Diabetes and Cardiovascular Disease-A Focus on New Therapies.

Dhindsa DS, Sandesara PB, Shapiro MD.

Front Cardiovasc Med. 2018 Nov 13;5:160. doi: 10.3389/fcvm.2018.00160. eCollection 2018. Review.

15.

Reclassifying Risk in Familial Hypercholesterolemia: The Power of a Coronary Artery Calcium Score of Zero.

Shapiro MD, Blankstein R.

JACC Cardiovasc Imaging. 2018 Nov 8. pii: S1936-878X(18)30931-8. doi: 10.1016/j.jcmg.2018.10.010. [Epub ahead of print] No abstract available.

PMID:
30448142
16.

"Taking a look under the hood"-imaging the phenotypic heterogeneity of familial hypercholesterolemia.

Shapiro MD, Fazio S.

J Clin Lipidol. 2018 Sep - Oct;12(5):1095-1098. doi: 10.1016/j.jacl.2018.05.020. Epub 2018 Jun 8. No abstract available.

PMID:
30318061
17.

The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.

Sandesara PB, Virani SS, Fazio S, Shapiro MD.

Endocr Rev. 2019 Apr 1;40(2):537-557. doi: 10.1210/er.2018-00184.

PMID:
30312399
18.

Biologic bases of residual risk of cardiovascular events: A flawed concept.

Shapiro MD, Fazio S.

Eur J Prev Cardiol. 2018 Nov;25(17):1831-1835. doi: 10.1177/2047487318798060. Epub 2018 Sep 10. No abstract available.

PMID:
30196721
19.

Introgression of regulatory alleles and a missense coding mutation drive plumage pattern diversity in the rock pigeon.

Vickrey AI, Bruders R, Kronenberg Z, Mackey E, Bohlender RJ, Maclary ET, Maynez R, Osborne EJ, Johnson KP, Huff CD, Yandell M, Shapiro MD.

Elife. 2018 Jul 17;7. pii: e34803. doi: 10.7554/eLife.34803.

20.

Medication-based versus target-based lipid management.

Fazio S, Shapiro MD.

J Diabetes. 2018 Oct;10(10):789-792. doi: 10.1111/1753-0407.12789. Epub 2018 Jul 2. No abstract available.

PMID:
29962061
21.

Withdrawn: "Taking a look under the hood"-Imaging the phenotypic heterogeneity of familial hypercholesterolemia.

Shapiro MD, Fazio S.

J Clin Lipidol. 2018 May 30. pii: S1933-2874(18)30248-4. doi: 10.1016/j.jacl.2018.05.019. [Epub ahead of print]

PMID:
29935932
22.

PCSK9: From Basic Science Discoveries to Clinical Trials.

Shapiro MD, Tavori H, Fazio S.

Circ Res. 2018 May 11;122(10):1420-1438. doi: 10.1161/CIRCRESAHA.118.311227. Review.

23.

PREDICTING HYPERTRIGLYCERIDEMIC PANCREATITIS - NOT SO FAST!

Shapiro MD, Fazio S.

Endocr Pract. 2018 May;24(5):495-497. doi: 10.4158/EP-2018-0121. Epub 2018 Apr 24. No abstract available.

PMID:
29688766
24.

Improved Genome Assembly and Annotation for the Rock Pigeon (Columba livia).

Holt C, Campbell M, Keays DA, Edelman N, Kapusta A, Maclary E, T Domyan E, Suh A, Warren WC, Yandell M, Gilbert MTP, Shapiro MD.

G3 (Bethesda). 2018 May 4;8(5):1391-1398. doi: 10.1534/g3.117.300443.

25.

Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor.

Shapiro MD, Miles J, Tavori H, Fazio S.

Ann Intern Med. 2018 Mar 6;168(5):376-379. doi: 10.7326/M17-2485. Epub 2017 Nov 28. No abstract available.

PMID:
29181527
26.

Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.

Amrock SM, Duell PB, Knickelbine T, Martin SS, O'Brien EC, Watson KE, Mitri J, Kindt I, Shrader P, Baum SJ, Hemphill LC, Ahmed CD, Andersen RL, Kullo IJ, McCann D, Larry JA, Murray MF, Fishberg R, Guyton JR, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Underberg JA, Thompson P, Duffy D, Linton MF, Shapiro MD, Moriarty PM, Knowles JW, Ahmad ZS.

Atherosclerosis. 2017 Dec;267:19-26. doi: 10.1016/j.atherosclerosis.2017.10.006. Epub 2017 Oct 6.

PMID:
29080546
27.

Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America.

Ladapo JA, Coles A, Dolor RJ, Mark DB, Cooper L, Lee KL, Goldberg J, Shapiro MD, Hoffmann U, Douglas PS.

BMJ Open. 2017 Sep 29;7(9):e016364. doi: 10.1136/bmjopen-2017-016364.

28.

Application of PCSK9 Inhibitors in Practice: Challenges and Opportunities.

Kaufman TM, Duell PB, Purnell JQ, Wójcik C, Fazio S, Shapiro MD.

Circ Res. 2017 Aug 18;121(5):499-501. doi: 10.1161/CIRCRESAHA.117.311532. Review. No abstract available.

PMID:
28819040
29.

Risk Factors for Mortality Among Individuals With Peripheral Arterial Disease.

Amrock SM, Abraham CZ, Jung E, Morris PB, Shapiro MD.

Am J Cardiol. 2017 Sep 1;120(5):862-867. doi: 10.1016/j.amjcard.2017.05.057. Epub 2017 Jun 15.

PMID:
28734461
30.

Setting the Agenda for Preventive Cardiology.

Shapiro MD, Fazio S.

Circ Res. 2017 Jul 21;121(3):211-213. doi: 10.1161/CIRCRESAHA.117.311390. Review. No abstract available.

PMID:
28729452
31.

Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.

Fazio S, Minnier J, Shapiro MD, Tsimikas S, Tarugi P, Averna MR, Arca M, Tavori H.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3340-3348. doi: 10.1210/jc.2016-4043.

32.

Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9.

Edmiston JB, Brooks N, Tavori H, Minnier J, Duell B, Purnell JQ, Kaufman T, Wojcik C, Voros S, Fazio S, Shapiro MD.

J Clin Lipidol. 2017 May - Jun;11(3):667-673. doi: 10.1016/j.jacl.2017.03.001. Epub 2017 Mar 9.

PMID:
28506388
33.

"Mutation-negative" familial hypercholesterolemia-When negative is positive.

Shapiro MD.

J Clin Lipidol. 2017 Mar - Apr;11(2):325-327. doi: 10.1016/j.jacl.2017.01.015. Epub 2017 Feb 6. No abstract available.

PMID:
28502487
34.

Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.

Shapiro MD, Fazio S.

Nat Rev Cardiol. 2017 Jun;14(6):319-320. doi: 10.1038/nrcardio.2017.66. Epub 2017 May 4. No abstract available.

PMID:
28470176
35.

Normative Data for a Comprehensive Neuropsychological Test Battery used in the Assessment of Sports-Related Concussion.

Merritt VC, Meyer JE, Cadden MH, Roman CA, Ukueberuwa DM, Shapiro MD, Arnett PA.

Arch Clin Neuropsychol. 2017 Mar 1;32(2):168-183. doi: 10.1093/arclin/acw090.

PMID:
28365744
36.

Genomic determinants of epidermal appendage patterning and structure in domestic birds.

Boer EF, Van Hollebeke HF, Shapiro MD.

Dev Biol. 2017 Sep 15;429(2):409-419. doi: 10.1016/j.ydbio.2017.03.022. Epub 2017 Mar 24.

37.

PCSK9 and Atherosclerosis - Lipids and Beyond.

Shapiro MD, Fazio S.

J Atheroscler Thromb. 2017 May 1;24(5):462-472. doi: 10.5551/jat.RV17003. Epub 2017 Mar 9. Review.

38.

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease.

Shapiro MD, Fazio S.

F1000Res. 2017 Feb 13;6:134. doi: 10.12688/f1000research.9845.1. eCollection 2017. Review.

39.

Phylogenomics using Target-Restricted Assembly Resolves Intrageneric Relationships of Parasitic Lice (Phthiraptera: Columbicola).

Boyd BM, Allen JM, Nguyen NP, Sweet AD, Warnow T, Shapiro MD, Villa SM, Bush SE, Clayton DH, Johnson KP.

Syst Biol. 2017 Nov 1;66(6):896-911. doi: 10.1093/sysbio/syx027.

40.

Pigeonetics takes flight: Evolution, development, and genetics of intraspecific variation.

Domyan ET, Shapiro MD.

Dev Biol. 2017 Jul 15;427(2):241-250. doi: 10.1016/j.ydbio.2016.11.008. Epub 2016 Nov 12. Review.

41.

TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.

Handelsman Y, Shapiro MD.

Endocr Pract. 2017 Jan;23(1):100-112. doi: 10.4158/EP161445.RA. Epub 2016 Nov 7. Review.

PMID:
27819772
42.

US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.

Ahmad ZS, Andersen RL, Andersen LH, O'Brien EC, Kindt I, Shrader P, Vasandani C, Newman CB, deGoma EM, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Kullo IJ, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW.

J Clin Lipidol. 2016 Sep-Oct;10(5):1223-9. doi: 10.1016/j.jacl.2016.07.011. Epub 2016 Aug 6.

43.

Applications of Advanced Imaging in Cardiac Electrophysiology.

Yadava M, Shapiro MD.

Curr Treat Options Cardiovasc Med. 2016 Nov;18(11):66. doi: 10.1007/s11936-016-0491-5. Review.

PMID:
27646314
44.

PCSK9 Association With Lipoprotein(a).

Tavori H, Christian D, Minnier J, Plubell D, Shapiro MD, Yeang C, Giunzioni I, Croyal M, Duell PB, Lambert G, Tsimikas S, Fazio S.

Circ Res. 2016 Jun 24;119(1):29-35. doi: 10.1161/CIRCRESAHA.116.308811. Epub 2016 Apr 27.

45.

Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.

deGoma EM, Ahmad ZS, O'Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW.

Circ Cardiovasc Genet. 2016 Jun;9(3):240-9. doi: 10.1161/CIRCGENETICS.116.001381. Epub 2016 Mar 24.

46.

Molecular shifts in limb identity underlie development of feathered feet in two domestic avian species.

Domyan ET, Kronenberg Z, Infante CR, Vickrey AI, Stringham SA, Bruders R, Guernsey MW, Park S, Payne J, Beckstead RB, Kardon G, Menke DB, Yandell M, Shapiro MD.

Elife. 2016 Mar 15;5:e12115. doi: 10.7554/eLife.12115.

47.

From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk.

Shapiro MD, Fazio S.

Circ Res. 2016 Feb 19;118(4):732-49. doi: 10.1161/CIRCRESAHA.115.306471. Review.

PMID:
26892970
48.

Familial Hypercholesterolemia: Genes and Beyond.

Warden BA, Fazio S, Shapiro MD.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2018 Dec 24.

49.

Wham: Identifying Structural Variants of Biological Consequence.

Kronenberg ZN, Osborne EJ, Cone KR, Kennedy BJ, Domyan ET, Shapiro MD, Elde NC, Yandell M.

PLoS Comput Biol. 2015 Dec 1;11(12):e1004572. doi: 10.1371/journal.pcbi.1004572. eCollection 2015 Dec.

50.

Rare Genetic Disorders Altering Lipoproteins.

Shapiro MD.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2018 Aug 15.

Supplemental Content

Loading ...
Support Center